Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
India · Delayed Price · Currency is INR 1,275.00
-0.20 (-0.02%)
Dec 3, 2025, 12:40 PM IST
Dr. Reddy's Laboratories Employees
Dr. Reddy's Laboratories had 27,811 employees as of March 31, 2025. The number of employees increased by 763 or 2.82% compared to the previous year.
Employees
27,811
Change (1Y)
763
Growth (1Y)
2.82%
Revenue / Employee
12.30M INR
Profits / Employee
2.11M INR
Market Cap
1.06T
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 27,811 | 763 | 2.82% |
| Mar 31, 2024 | 27,048 | 1,185 | 4.58% |
| Mar 31, 2023 | 25,863 | 1,068 | 4.31% |
| Mar 31, 2022 | 24,795 | 2,056 | 9.04% |
| Mar 31, 2021 | 22,739 | 1,089 | 5.03% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Apollo Hospitals Enterprise | 42,497 |
| Cipla | 30,313 |
| Zydus Lifesciences | 27,917 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 26,978 |
| Alkem Laboratories | 18,785 |
| Glenmark Pharmaceuticals | 15,800 |
Dr. Reddy's Laboratories News
- 5 hours ago - Dr Reddy’s can make Novo’s weight loss drug, rules HC - The Times of India
- 18 hours ago - Aurigene Oncology Limited Announces Encouraging Initial Data From 1st Two Cohorts of Phase 1 Study of AUR112, an Oral Small Molecule Inhibitor of MALT1, in Relapsed/Refractory Lymphoid Malignancies - Business Wire
- 21 hours ago - Nifty 50 top gainers today, December 2: Asian Paints, Dr. Reddy’s Laboratories, Maruti Suzuki India, Bharti Airtel and more - Business Upturn
- 6 days ago - Dr. Reddy’s Laboratories arm Aurigene Oncology receives GST appellate order - Business Upturn
- 8 days ago - Biosimilar push: Dr Reddy’s gets EU nod for denosumab copy; Prolia, Xgeva rivals set for rollout - The Times of India
- 8 days ago - Dr. Reddy’s Laboratories receives European Commission approval for AVT03 - Business Upturn
- 13 days ago - Dr. Reddy's Laboratories Breaks Above 200-Day Moving Average - Bullish for RDY - Nasdaq
- 18 days ago - Dr. Reddy’s API facility clears USFDA GMP inspection with zero observations - Business Upturn